Literature DB >> 2989726

Metastasis of an occult gastric carcinoma suggesting growth of a prolactinoma during bromocriptine therapy: a case report with a review of the literature.

A P van Seters, G T Bots, H van Dulken, W Luyendijk, G J Vielvoye.   

Abstract

The treatment of a slowly growing invasive prolactinoma with bromocriptine for 8 months resulted in a substantial decrease in plasma prolactin levels despite rapid suprasellar tumor expansion. On exploration, this uncommon observation could be attributed to hematogenous metastasis from an occult gastric adenocarcinoma to the pituitary tumor. Apart from infiltration of neighboring parts of the hypothalamus, autopsy revealed no other hematogenous metastases. This extraordinary type of neoplasm-to-neoplasm metastasis was not shown by computed tomography. This possibility should be considered whenever progressive growth of a pituitary mass is accompanied by a decrease in hormonal overproduction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989726     DOI: 10.1227/00006123-198506000-00014

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

Review 1.  Diagnosis and management of isolated pituitary metastasis from adenocarcinoma of unknown origin presenting as loss of libido.

Authors:  Julien Feghaly; George Astras
Journal:  BMJ Case Rep       Date:  2015-03-31

Review 2.  Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review.

Authors:  Ribal Al-Aridi; Katia El Sibai; Pingfu Fu; Mehreen Khan; Warren R Selman; Baha M Arafah
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

3.  Pituitary Metastatic Composite Tumors: A Case Report with Next-Generation Sequencing and Review of the Literature.

Authors:  Matthew Helton; Muhammad Abu-Rmaileh; Kevin Thomas; Murat Gokden; Alissa Kanaan; Analiz Rodriguez
Journal:  Case Rep Oncol Med       Date:  2020-07-21

4.  Metastatic renal cell carcinoma to the pituitary presenting with hyperprolactinemia.

Authors:  S Basaria; W H Westra; H Brem; R Salvatori
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

5.  Extended Survival After Surgical Resection for Pituitary Metastases: Clinical Features, Management, and Outcomes of Metastatic Disease to the Sella.

Authors:  Krupa R Patel; Junting Zheng; Viviane Tabar; Marc A Cohen; Monica Girotra
Journal:  Oncologist       Date:  2019-11-29

Review 6.  Progressive visual disturbance and enlarging prolactinoma caused by melanoma metastasis: A case report and literature review.

Authors:  Chuanwei Yang; Ling Liu; Xiaoqiang Lan; Shiqiang Zhang; Xinyu Li; Bo Zhang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

7.  Hyperprolactinemia due to pituitary metastasis: A case report.

Authors:  Chun-Yang Liu; Yu-Bo Wang; Hui-Qin Zhu; Jin-Liang You; Zhuang Liu; Xian-Feng Zhang
Journal:  World J Clin Cases       Date:  2021-01-06       Impact factor: 1.337

8.  Oculomotor Paralysis, Postorbital Pain, and Hypopituitarism as First Presentations of Metastatic Gastric Cancer in the Pituitary Flourished by Internal Carotid Aneurysm: A Case Report.

Authors:  Chuanwei Yang; Hongqiang Zhang; Shiqiang Zhang; Ling Liu; Binbin Ma; Jiacheng Lou; Xiaorui Sun; Bo Zhang
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.